Skip to main content
Clinical Trials/CTRI/2022/12/048454
CTRI/2022/12/048454
Recruiting
Phase 2

Randomized Controlled Trial of Vidangadi Guggul compare with Dhatri Nishe in Madhumeha with special reference to Type II Diabetes Mellitus.

Government Ayurved College and Hospital Nagpur0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Government Ayurved College and Hospital Nagpur
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Government Ayurved College and Hospital Nagpur

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who are willing to participate in trial and ready to give written
  • 2\. Patients of type II DM of 30 to 70 years of age, irrespective of sex.
  • 3\. Newly detected patients as well as the patient who are not responding to any
  • oral hypoglycemic agents and blood sugar level is as below of type II DM.
  • 4\. Patients with fasting blood sugar ranges from 110\-200 mg/dl and post prandial
  • blood sugar ranges from 180\-250 mg/dl, with clinical signs and symptoms of
  • 5\. Glycosylated hemoglobin (HbA1C) range 6\.5 % \- 10%.
  • 6\. Patient who are diagnosed in routine check\-up or present with
  • other complaints in the hospital.
  • 7\. Patient who has not participated in any research project in last 6 months.

Exclusion Criteria

  • 1\. Patients having fasting blood sugar level \>200mg/dl and post meal
  • blood sugar level \>250 mg/dl.
  • 2\. Patients who are not willing to participate in trial and not ready to give
  • written consent.
  • 3\. Patients having age below 30 and above 70 years.
  • 4\. Pregnant women and lactating mothers.
  • 5\. Acute complications of hyperglycemia like DKA (Diabetic Ketoacidosis).
  • 6\. Type 1 DM, Gestational DM and patient on insulin therapy.
  • 7\. Patients suffering from the serious macrovascular and microvascular
  • complications of DM.

Outcomes

Primary Outcomes

Not specified

Similar Trials